Raymond James & Associates’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-90
| Closed | -$25K | – | 3620 |
|
|
2019
Q1 | $25K | Sell |
90
-7
| -7% | -$1.94K | ﹤0.01% | 3451 |
|
|
2018
Q4 | $12K | Hold |
97
| – | – | ﹤0.01% | 3410 |
|
|
2018
Q3 | $40K | Sell |
97
-44
| -31% | -$18.1K | ﹤0.01% | 3446 |
|
|
2018
Q2 | $76K | Sell |
141
-334
| -70% | -$180K | ﹤0.01% | 3383 |
|
|
2018
Q1 | $219K | Sell |
475
-6
| -1% | -$2.77K | ﹤0.01% | 3066 |
|
|
2017
Q4 | $322K | Buy |
481
+47
| +11% | +$31.5K | ﹤0.01% | 2774 |
|
|
2017
Q3 | $273K | Buy |
434
+88
| +25% | +$55.4K | ﹤0.01% | 2836 |
|
|
2017
Q2 | $166K | Buy |
+346
| New | +$166K | ﹤0.01% | 3000 |
|